News: MYX Mayne Pharma Posts HY Loss From Ordinary Activities After Income Tax Expense A$50.6 Mln, page-5

@silver Selling got nothing to do with our recent company report ( relatively good considering ) apart from Russia / China upsetting pretty much everything right now cant see ex directors holding shares such as BM , RC and the remainder of Nolan holding most of her holding been sold , can be sure if SR goes he'll most likely sell his massive holding too . Asset value exceeding Market Cap by miles always been obvious to see , MYX hopelessly undervalued , value of owned assets not taken into account . Merchant Bank Groups like Lazard major holders in and out of Mayne on a regular basis don't think good ( considering what they do / specialize in ) for a company such as ours damaged by poor management saddled with high high debt running at a net loss . Company presently hopelessly undervalued by the market , Cap (US) $293 M. Not hard to see Mayne's vulnerability targeted by some predatorial entity . .